BMO Capital analyst Matt Borsch downgrades Universal Health Services (NYSE:UHS) from Market Perform to Underperform and announces $90 price target.
Barclays Maintains Overweight on Essent Gr, Lowers Price Target to $54
Barclays analyst Mark Devries maintains Essent Gr (NYSE:ESNT) with a Overweight and lowers the price target from $72 to $54.